Verge Medical Acquires RoVo™ System to Advance Peripheral Embolic Protection

Verge Medical Acquires RoVo™ System to Advance Peripheral Embolic Protection

CAMPBELL, Calif., June 30, 2025 /PRNewswire/ -- Verge Medical, a privately held medical technology company focused on advancing physician-driven solutions to address persistent gaps in vascular care, today announced the acquisition of the RoVo™ System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The acquisition enhances Verge's expanding

Verge Medical Acquires RoVo System for Peripheral Embolic Protection - Endovascular Today

June 30, 2025—Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG Medical. The FDA-cleared RoVo system addresses the risk of distal embolization with its TOE technique during atherectomy and other peripheral interventions. According to the company, the TOE technique temporarily blocks downstream blood flow through compression while a vacuum-activated catheter is advanced an…